Transient Retinal Symptoms of Vascular Origin

Definition and Classification

Transient monocular vision loss (TMVL) of vascular origin is a retinal transient ischemic attack (TIA), characterized by sudden, painless loss of vision in one eye that clears within seconds to minutes, according to the American Academy of Ophthalmology 1, 2, 3
TMVL is part of the spectrum of acute retinal arterial ischemia, which also includes branch retinal artery occlusion (BRAO) and central retinal artery occlusion (CRAO), as defined by the American Heart Association 3
These conditions reflect acutely impaired blood flow in the anterior cerebral and ocular circulation, as stated by the American College of Cardiology 1

The American Heart Association defines retinal cell death attributable to ischemia as a stroke equivalent, emphasizing the seriousness of TMVL 3
TMVL represents a serious condition on the spectrum of brain and eye ischemia, with a risk of stroke after retinal TIA that may be lower than after cerebral TIA, but with an overall risk for cardiovascular events and death that remains similar, according to the American Stroke Association 4
The risk of stroke is maximum within the first few days after onset of visual symptoms, highlighting the need for prompt diagnosis and treatment, as recommended by the American Academy of Neurology 1

Prompt and accurate diagnosis is essential due to the risk of subsequent stroke, with guidelines recommending urgent brain MRI with diffusion-weighted imaging, vascular imaging, and clinical assessment to identify patients at highest risk for recurrent stroke, as stated by the American College of Radiology 1
The American Heart Association recommends a comprehensive diagnostic approach, including brain MRI and vascular imaging, to evaluate patients with TMVL 1

TMVL requires immediate referral to specialized stroke centers without delay, with treatment following the same protocols as for cerebral TIAs, as recommended by the American Stroke Association 1, 3
Early preventive treatments are crucial to reduce the risk of subsequent stroke and cardiovascular events, emphasizing the importance of prompt diagnosis and treatment, according to the American College of Cardiology 1
Collaboration among optometrists, ophthalmologists, and stroke neurologists is essential for effective management of TMVL, as stated by the American Academy of Ophthalmology 1

The American Heart Association considers amaurosis fugax as a transient ischemic attack (TIA) equivalent, requiring immediate evaluation in a stroke center 5
A description of "half vision" for 30 minutes is typically consistent with transient retinal ischemia 6
The risk of stroke is highest in the first few days following the onset of visual symptoms, necessitating rapid diagnosis and treatment 5
The American College of Radiology recommends immediate brain MRI with diffusion sequences to identify patients at high risk of recurrent stroke 7
Giant cell arteritis (GCA) should be considered in patients over 50 years old presenting with transient vision loss, with a likelihood ratio (LR) of 1.51 for GCA 8
Jaw claudication is the most specific symptom for GCA, with an LR of 4.90 8
An erythrocyte sedimentation rate (ESR) > 60 mm/h has a high LR for GCA 8

Immediate brain MRI with diffusion sequences is the examination of choice to exclude acute ischemic or hemorrhagic stroke 7
Vascular imaging (MRA or CTA) should be performed to evaluate the carotids, as significant carotid stenosis is found in up to 70% of patients with symptomatic retinal vascular events 5
Laboratory tests, including ESR and CRP, should be performed urgently in patients over 50 years old with suspected GCA 8

Patients with sudden vision loss should be referred immediately to a specialized stroke center without attempting further examinations 5
The American College of Cardiology recommends controlling cardiovascular risk factors, such as hypertension, diabetes, and dyslipidemia, to prevent secondary stroke 5